BioCentury
ARTICLE | Financial News

Kiadis raises EUR 32.7M in IPO

July 2, 2015 12:47 AM UTC

Kiadis Pharma B.V. (Euronext:KDS) raised EUR 32.7 million ($36.2 million) through the sale of 2.6 million shares at EUR 12.50 in an IPO underwritten by Kempen; KBC Securities; and Peel Hunt. The IPO price values the company at EUR 166.4 million ($184.2 million). Kiadis expects its shares to begin trading on Thursday.

Last month, Kiadis said it hoped to sell 2.3 million shares at EUR 11-13.75. A sale of that many shares at the midpoint of EUR 12.38 would have raised EUR 28.1 million ($31.1 million) and valued the company at EUR 160.5 million ($177.6 million). ...